For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Penn Live
Harrisburg is taking a wrong approach to drug pricing | PennLive letters
CEI’s Joel Zinberg was cited in a Penn Live article on Pharmacy Benefit Managers: Joel Zinberg from the Competitive Enterprise Institute (CEI) explains, “PBMs enhance…
Politico
Biden’s got a plan to protect science from Trump
CEI’s Joel Zinberg was cited in Politico on the obstacles Trump faces with the NIH: Trump should have no illusions about what he’s up against,…
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
Search Posts
Study
Freedom Wins
ABOUT THE AUTHORS Joel M. Zinberg, M.D., J.D. is the Director the Public Health and American Well-Being Initiative at Paragon Health Institute, and a senior…
Blog
Fauci Failure to Acknowledge Limited Vaccine Protection Undermines Faith in Government Advice
In a recent article Dr. Anthony Fauci acknowledged that, from the beginning of the pandemic, there was good reason to believe that vaccines against…
Regulatory Transparency Project
AUDIO: Explainer Episode 48 – The FDA & the Practice of Medicine: Possible Regulation of Off-Label Prescriptions
Senior Fellow Joel Zinberg joins the Regulatory Transparency Project to discuss possibly regulation of off-label prescriptions: On December 29, 2022, President Biden signed the Consolidated Appropriations…
Citation
FDA’s Medical Interference, Time for ESG Antitrust Action and other commentary
Libertarian: FDA’s Medical Interference The Wall Street Journal quoted Joel Zinberg on FDA banning practices: “Secreted within the 2023 omnibus appropriations…
Wall Street Journal
The FDA Wants to Interfere in the Practice of Medicine
Secreted within the 2023 omnibus appropriations bill—4,155 pages, spending $1.7 trillion—is a 19-line section that could change the way medicine is practiced. Physicians routinely prescribe…
City Journal
PODCAST: The Last Gasp of Pandemic Restrictions?
Senior Fellow Joel Zinberg joins Brian Anderson at City Journal to discuss the “tripledemic” of Covid, flu and RSV, the relationship of public health and…